RxDoctor Payments Data

John Bondhus, PA

Physician Assistant · Hot Springs National Park, ARNPI 1679641997

Payments from drug & device makers

$905in general payments, 2019–2025

Across 25 payments — averaging $36.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$312
  • Johnson & Johnson$226
  • Vertex$121
  • EMD Serono, Inc.$120
  • Genentech USA, Inc.$33
  • Pfizer$30
  • plus $64 from 4 others

What the payments were for

  • Food & beverage$905100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$905 in reported general payments places this provider in the 60th percentile of 451 physician assistant providers in Arkansas.

See all physician assistant providers in Arkansas

Medicare billing

Part B allowed, 2024
$91,775
Medicare patients
769
Services billed
4,876

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lagevrio (Eua)Molnupiravir11$7,209
Albuterol Sulfate HfaAlbuterol Sulfate75$2,406
Ventolin HfaAlbuterol Sulfate37$2,047
PaxlovidNirmatrelvir/Ritonavir55$1,429
Doxycycline Hyclate127$1,391
Diclofenac Sodium48$1,025
Azithromycin168$648
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst55$644
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav64$575
Cefdinir35$541
Oseltamivir Phosphate24$482
Cephalexin73$454
Clindamycin Hcl30$425
Hydrocortisone Valerate15$390
Ondansetron OdtOndansetron25$376

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$30$1,42955 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 451 physician assistant providers in Arkansas.

Other physician assistant in Hot Springs National Park

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →